The association between serum levels of growth differentiation factor-15 and rheumatoid arthritis activity

Kamal Esalatmanesh1, Hamidreza Fayyazi1, Roozbeh Esalatmanesh1

  • 1Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.

Abstract

Insights

Growth Differentiation Factor-15 (GDF-15) shows promise as a biomarker for rheumatoid arthritis (RA) activity. Elevated serum GDF-15 levels accurately predict high RA disease activity, aiding in patient management.

Area of Science:

  • Rheumatology
  • Immunology
  • Biomarker Discovery

Background:

  • Macrophages are key players in rheumatoid arthritis (RA) pathogenesis.
  • Growth Differentiation Factor-15 (GDF-15) regulates macrophage activation.

Purpose of the Study:

  • To evaluate serum GDF-15 as a potential biomarker for RA disease activity.
  • To correlate GDF-15 levels with varying degrees of RA activity.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure serum GDF-15.
  • Study included 100 female RA patients and 55 healthy female controls.

Main Results:

  • Serum GDF-15 levels were significantly higher in RA patients with high disease activity (989.0 ± 161.9 pg/mL).
  • A GDF-15 cutoff >705 pg/mL predicted high RA activity with 96% sensitivity and 92% specificity.

Conclusions:

  • Serum GDF-15 levels can serve as a valuable biomarker for predicting high rheumatoid arthritis disease activity.
  • GDF-15 may assist in clinical assessment and management of RA patients.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
328
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
324